By

Chad Robins

10
Jun
2021

T-cell Diagnostic Tests: COVID-19 Pushed Us, and We Can See Where This Leads

In late February 2020, when it became clear that COVID-19 was spreading around the world, our senior management team at Adaptive Biotechnologies took a gamble. We had a hunch that our ability to evaluate T-cell immunity, combined with advanced bioinformatics, could help the scientific community better understand the novel coronavirus. The entire world, it seemed, was focused on B-cell derived...
Read More